Acuta Capital Partners’s Rigel Pharmaceuticals RIGL Stock Holding History

Acuta Capital Partners’s Portfolio RIGL Stock Details RIGL Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Hold
2016 Q3	–	Sell
2016 Q2	$1.67M	Sell
2016 Q1	$1.62M	Buy
2015 Q4	$1.38M	Buy
2015 Q3	$494K	Buy